Chemed Corporation (CHE) Reports In-Line Q4 EPS, Offers Guidance

Chemed Corporation (NYSE: CHE) reported Q4 EPS of $5.13, in-line with the analyst estimate of $5.13. Revenue for the quarter came in at $533.3 million versus the consensus estimate of $537.2 million.

GUIDANCE:

Chemed Corporation sees FY2021 EPS of $17.00-$17.50, versus the consensus of $17.28.

• Based upon the above, full-year 2021 adjusted earnings per diluted share, excluding non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation, and other discrete items, is estimated to be in the range of $17.00 to $17.50. This 2021 guidance assumes an effective corporate tax rate on adjusted earnings of 24.7%. Chemed’s 2020 reported adjusted earnings per diluted share was $18.08.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.

You May Also Be Interested In

• Johnson & Johnson (JNJ) Tops Q1 EPS by 25c, Updates Guidance
• Surgery Partners (SGRY) Provides Preliminary First Quarter 2021 Financial Performance Update
• Chinese demand, higher prices boost BMW's first-quarter earnings